A 150-bed surgical hospital in Nagpur processing 380 insurance claims monthly at an average INR 42,000 generates about INR 1.6 crore in insured receivables each month. With a 90-day average settlement cycle, roughly INR 4.8 crore remains continuously in the payment pipeline. The revenue is earned and will eventually be paid by the insurer, but the hospital cannot access it for three months after care. Meanwhile, salaries, supplies, and vendor invoices follow a 30-day cycle.
The 90-day figure is the median, not a worst case. Significant rejection and resubmission can push effective payment cycles to 120 or 150 days for part of insured volume. Where insured patients account for 40-60% of admissions, this is a structural operating issue, not a marginal cash flow concern.
The Numbers Behind the Problem
The scale must be calculated from each hospital's own patient mix, average claim value, and insured-volume percentage, rather than from industry averages.
Begin with monthly insured revenue: multiply insured discharges by average claim value. For a 150-bed secondary care hospital in a Tier 2 city, 300 to 500 monthly discharges at INR 30,000 to 55,000 per claim produce INR 90 lakh to INR 2.75 crore in monthly insured revenue.
Multiply monthly revenue by three for a 90-day settlement cycle. This is the standing receivables balance owed to the hospital and waiting in the TPA/insurer queue. For the Nagpur example, it is INR 4.8 crore.
Then apply the rejection rate. If 28% of claims are rejected initially and require another 60 to 90 days, part of the INR 4.8 crore faces a 150 to 180-day settlement cycle. The rejected and resubmitted sub-pool therefore has a larger pipeline balance and slower cash conversion.
The key question is how much operating cash must be raised externally each month while insurance payments are pending. With INR 1.6 crore in monthly insured revenue and a 90-day cycle, the working capital gap is about INR 3.2 crore: two months of operations require bridging finance, while month three's receipts cover month one's costs.
How Hospitals Manage It Today
Hospitals usually cover the insurance-payment gap through several methods, none designed specifically for it.
Overdraft facilities. Most hospitals use a cash credit or overdraft line from their primary bank. For hospitals with good credit, rates typically run 11-14% per annum, above the implicit cost of the insurance float. The hospital draws and repays the facility as settlements arrive, making the bank an involuntary short-term lender against insurance receivables.
Deferring vendor payments. Under cash pressure, hospitals extend terms with medical consumables suppliers, pharmaceutical distributors, and equipment maintenance vendors. The hidden costs include supply disruption, lost early-payment discounts, and weaker critical-vendor relationships. A hospital losing a 2% discount on INR 60 lakh in monthly consumable purchases gives up INR 1.2 lakh monthly in implicit interest, often above its bank overdraft cost.
Delaying capital expenditure. Equipment replacement, facility upgrades, and technology investments are postponed because the cash exists in receivables but has not arrived. This pattern contributes directly to the technology and infrastructure gap many mid-size Indian hospitals carry against their clinical quality aspirations.
Drawing on promoter capital. In owner-operated hospitals, the promoter family often supplies informal bridging capital at no explicit cost, funding the working capital deficit from personal savings or other business lines. This conceals the insurance-gap cost in the financial statements.
How Rejections Widen the Gap
A predictable 90-day settlement cycle is manageable. High rejection rates disrupt that cadence, producing cash flow lumps instead of a smooth curve.
A hospital submitting INR 1.6 crore in claims monthly, with a 25% rejection rate, sends INR 40 lakh from each month's submissions into resubmission rather than the normal settlement pipeline. These claims eventually settle, but not within 90 days. They arrive irregularly, in lumps three to five months after submission, making cash flow forecasting difficult.
Reducing rejection from 28% to 10% does more than cut administrative work. It makes cash flow more predictable, improving decisions on vendor-payment timing, capital expenditure, and overdraft use. Rejection improvement and cash flow predictability are two views of the same issue.
Operational Effects of the Gap
The cash flow gap extends beyond finance, affecting hospital operations in ways rarely linked to its root cause.
Medical equipment purchases may be postponed or compromised. A hospital due to replace an ultrasound machine in the June quarter may defer it to September because insurance receivables have not cleared. Clinical teams then use older equipment, affecting diagnostic quality and physician satisfaction.
Salary cycles come under pressure when large claim batches remain in TPA queries or dispute resolution. Where payroll is the largest monthly cash outflow, the mismatch between insurance receipts and payroll dates creates recurring stress, managed through bank lines not designed for it.
Pharmaceutical and consumable procurement becomes reactive. With cash constrained by delayed insurance receipts, purchase managers reduce order sizes, causing higher unit costs, more frequent orders, and occasional stockouts. The measurable efficiency loss traces back to the insurance payment gap.
Three Ways to Close the Gap
Hospitals have three structural options, each with different costs and operating requirements.
Reduce the rejection rate. Each percentage-point reduction in first-submission rejection improves cash conversion speed and predictability. Cutting rejection from 30% to 15% shifts INR 24 lakh monthly, at INR 1.6 crore volume, from the slow resubmission track to the standard 90-day track. The benefit compounds over time. Better billing-process quality is the right starting point before considering financing.
Negotiate faster payment terms. Some hospitals, especially larger networks, have secured expedited terms with particular TPAs or insurers, reducing settlement from 90 days to 45-60 days for part of their volume. This generally requires volume commitments, directing patients to the insurer's network, audit cooperation, and maintained claims-quality standards. It is not available to every hospital, and cycle-time gains are often partial.
Receivables-based financing. Insurance receivables can support a short-term advance instead of a general-purpose overdraft. The advance is secured against specified receivables, limited by their value rather than general creditworthiness, and repaid directly from insurer payments rather than the hospital's operating account.
When Receivables Financing Beats a Credit Line
Overdraft facilities are not inherently wrong for hospital cash management. They work adequately for hospitals with controlled rejection rates, predictable settlement cycles, and strong bank relationships. Their cost is known, the facility is flexible, and administrative overhead is low.
Receivables-based financing is more attractive in three cases. First, when the overdraft is fully used or near its limit and more working capital is needed without increasing total debt. Second, when receivables quality is better than general creditworthiness suggests, allowing a better advance rate than a general credit facility. Third, when the hospital wants fewer personal guarantees: the financing is typically secured against the receivable, not the promoter's personal assets, a meaningful distinction for owner-operators.
Receivables financing still carries a cost through a factoring fee or advance discount. The economics generally support it when that cost is below the combined implicit cost of deferred vendor payments and the opportunity cost of deferred capital investment. Comparing the full cost of current workarounds, not only overdraft interest, usually clarifies the choice.
The 90-day insurance payment cycle will not change quickly, and its management options are established. Most hospitals should address both ends: reduce rejection to shrink the slow-track receivables pool, then consider financing the remainder if it costs less than current alternatives. Can your hospital quantify both sides of that comparison?